Skip to main content
. Author manuscript; available in PMC: 2009 Mar 30.
Published in final edited form as: Cancer Res. 2008 May 1;68(9):3532–3539. doi: 10.1158/0008-5472.CAN-07-6471

Table 3.

Risk of Squamous Cell Cervical Cancer Associated with HLA class II DRB1 and DQB1 alleles

Controls
(N=538)
Cases
(n=538)
n % n % OR1 95% CI Holm
P value2
DRB1*0101 79 (14.7) 80 (14.9) 1.1 (0.8-1.5)
DRB1*0301 135 (25.3) 100 (18.6) 0.7 (0.5-1.0) 0.08
DRB1*0401 100 (18.6) 121 (22.5) 1.4 (1.0-1.8) 0.22
DRB1*0404 48 (8.9) 39 (7.2) 0.8 (0.5-1.3)
DRB1*0701 139 (25.8) 132 (24.5) 1.0 (0.7-1.3)
DRB1*0801 30 (5.6) 25 (4.6) 0.9 (0.5-1.5)
DRB1*1101 33 (6.1) 65 (12.1) 2.1 (1.3-3.2) 0.001
DRB1*1301 59 (11.0) 40 (7.4) 0.7 (0.4-1.0)
DRB1*1302 49 (9.1) 28 (5.2) 0.5 (0.3-0.9) 0.03
DRB1*1401 25 (4.6) 28 (5.2) 1.1 (0.6-1.9)
DRB1*1501 143 (26.6) 147 (27.3) 1.1 (0.8-1.4)
DQB1*02 225 (41.8) 183 (34.0) 0.7 (0.6-1.0) 0.04
 DQB1*02013 135 (25.1) 100 (18.6) 0.7 (0.5-1.0) 0.08
 DQB1*02023 101 (18.8) 87 (16.2) 0.9 (0.6-1.2)
DQB1*0301 169 (31.4) 216 (40.1) 1.5 (1.1-1.9) 0.003
DQB1*0302 119 (22.1) 111 (20.6) 0.9 (0.7-1.2)
DQB1*0303 55 (10.2) 64 (11.9) 1.2 (0.8-1.7)
DQB1*0402 23 (4.3) 28 (5.2) 1.1 (0.6-1.9)
DQB1*0501 100 (18.6) 106 (19.7) 1.1 (0.8-1.5)
DQB1*0503 23 (4.3) 28 (5.2) 1.2 (0.7-2.1)
DQB1*0602 146 (27.1) 147 (27.3) 1.0 (0.8-1.4)
DQB1*0603 61 (11.3) 43 (8.0) 0.7 (0.5-1.0)
DQB1*0604 35 (6.5) 21 (3.9) 0.6 (0.3-1.0)
1

Odds ratios are adjusted for race. Bolding represents significant associations, although rounding sometimes caused confidence intervals to include 1.0.

2

The Holm p value corrects the Wald p value for multiple comparisons and was based on all alleles at a locus and is only shown for alleles with significant odds ratios.

3

DQB1*02 could not be discerned as *0201 versus *0202 by the assay; see the Methods section.